Biggest News Aggregation in the World
๐Ÿ“ฐ Its Correlation News

Its Correlation News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Its Correlation. Real-time updates on events, politics, business and more.

International Stroke Conference 2024 to Present High-Profile Late-Breaking Science

The International Stroke Conference 2024 will be held Feb. 7-9 in Phoenix, Arizona. According to program planners with the American Stroke Association, a division of the American Heart Association, findings from late-breaking science will include multiple high profile randomized clinical trials like RESILIENT-Extend, EMBOLISE, STEM, ZODIAC, among many others.
New York United States Israel General Hong Kong Palo Alto Uxin Jiang

Harmonizing Talent and Symphony of HR Insights: IIM Jammu's International HR Conference and HR Conclave 6.0 concludes on a grand note. – India Education | Latest Education News | Global Educational News

Jammu: Indian Institute of Management (IIM) Jammu commenced the second day of the HR Conclave with session chair and keynote Speakers Mr. Ashissh Kaul, Director โ€“ Knowledge and Advisory & Business, Head, SHRM India, and Mr. Rohith Kumar, CHRO, Mc
Andhra Pradesh West Bengal Jammu And Kashmir Charitha Paramanandam Baljeet Singh Sani Rekha Manola

The APCO Bone Health QI Tool Kit - Putting a brake on fractures in the world's most populous & fastest ageing region

Asia Pacific Consortium on Osteoporosis (APCO) has launched a comprehensive Bone Health QI Tool Kit today to promote quality improvement (QI) of osteoporosis care.SINGAPORE, May 24, 2022 - (ACN Newswire)
Kostenloser Wertpapierhandel Manju Chandran Asia Pacific Greg Lyubomirsky Philippe Halbout International Osteoporosis Foundation

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Health Canada approves Zolgensma®, the one-time gene therapy for pediatric patients with spinal muscular atrophy (SMA)

Share this article ย  SMA is a rare genetic disease that leads to progressive muscle weakness, paralysis and, when left untreated in its most severe form, permanent ventilation or death for most patients by age 2 2,3 Zolgensma (onasemnogene abeparvovec) is approved for the treatment of pediatric SMA patients with 3 or fewer copies of the SMN2 gene, or infantile-onset SMA 1 Zolgensma is designed to address the genetic root cause of SMA by replacing the missing or defective SMN1 gene to halt dise...
City Of United Kingdom British Columbia Nicolas Chrestian Susi Vander Wyk Julie Schneiderman

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science